Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference52 articles.
1. Isaacson PG, Piris MA, Berger F, Swerdlow SH, Thieblemont C, Pittaluga S et al. Splenic B-cell marginal zone lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds). WHO Classification of Tumous of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer: Lyon, 185–187 2008.
2. Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M et al. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 2006; 107: 4643–4649.
3. Montalban C, Abraira V, Arcaini L, Domingo-Domenech E, Guisado-Vasco P, Iannito E et al. Risk stratification for splenic marginal zone lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases. Br J Haematol 2012; 159: 164–171.
4. Olszewski AJ, Castillo JJ . Survival of patients with marginal zone lymphoma: analysis of the surveillance, epidemiology, and end results database. Cancer 2013; 119: 629–638.
5. Arcaini L, Bruno R . Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas. Curr Clin Pharmacol 2010; 5: 74–81.
Cited by
143 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献